Nanoparticle-Based Drug Delivery Systems for the Treatment of Ocular Diseases
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 10 February 2025 | Viewed by 561
Special Issue Editor
Interests: nanoparticles; drug delivery; retinal degeneration; protein nanoparticles; nanomedicine
Special Issue Information
Dear Colleagues,
The eye itself is an organ that presents unfavourable anatomical and physiological barriers to drug delivery, particularly in the posterior segment. However, nanotechnology has been shown to overcome the challenges of ocular drug delivery, improving both efficacy and precision in the treatment of ocular diseases. These systems allow for the prolonged retention and better targeting of drugs to specific therapeutic sites and are increasingly overcoming the related barriers. In this work, we explore how different drug-loaded nanotechnology systems are characterised physicochemically, and we perform ex vivo and in vivo assays to improve therapeutic outcomes in ocular diseases and their treatment efficacy.
Prof. Dr. Daniela Alejandra Quinteros
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- anterior segment
- posterior segment
- drug delivery systems
- nanotechnology
- ocular diseases
- ocular barriers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
